← Back to all signals
RESEARCH PAPER ANALYSIS

Vertically Oriented Assembly of a Few-Layer Ti3C2Tx Grid by Electric Field Inducing and Freeze Drying for Wearable Levodopa Sensing in Sweat.

This paper presents a vertically oriented Ti3C2Tx (MXene) grid electrode loaded with Au as a wearable microfluidic electrochemical sensor that detects levodopa in sweat with two linear ranges (1–30 µM and 30–160 µM) and a 37 nM detection limit, integrated into a flexible electronic system and…

PMID41972294
JournalACS sensors
Publication Date2026-04-24
Ingested2026-04-28 08:58 PM
EXECUTIVE SUMMARY

What the AI sees

This paper presents a vertically oriented Ti3C2Tx (MXene) grid electrode loaded with Au as a wearable microfluidic electrochemical sensor that detects levodopa in sweat with two linear ranges (1–30 µM and 30–160 µM) and a 37 nM detection limit, integrated into a flexible electronic system and…

WHY IT MATTERS

Research significance

Offers a translational, high‑sensitivity wearable platform for real‑time levodopa monitoring to support personalized dosing and symptom management in Parkinson's patients, though it does not address disease mechanisms or new therapeutic targets.

ABSTRACT

Source abstract

Compared with the parallel assembly, the vertical assembly of MXene nanosheets on the substrate exhibits open three-dimensional porous structure, which is beneficial to the construction of high-performance electrodes. Herein, the vertically oriented assembly of Ti3C2Tx nanosheets is proposed by a novel preparation process of electric field inducing and freeze drying, resulting in the Ti3C2Tx grid with thin-wall and open porous structure. First, the electric field induces the formation of Ti3C2Tx hydrogel layer on the substrate. Second, freeze drying causes the growth of ice crystals for squeezing few-layer Ti3C2Tx nanosheets to stand up. More importantly, such a Ti3C2Tx grid with large surface area and intrinsic conductivity can effectively load electrocatalysts, resulting in the Au-Ti3C2Tx grid as a high-performance working electrode for the electrochemical detection of levodopa. The main parameters include 1-30 μM and 30-160 μM two-stage linear ranges and 37 nM detection limit. The structural advantages of Ti3C2Tx grid-based electrode materials are their three-dimensional conductive network and interconnected porous structure, which contribute to the penetration of the electrolyte, the diffusion of the analyte, and the electrocatalytic reaction. Furthermore, the self-adapting shape of the Ti3C2Tx grid leads to the fan-shaped Au-Ti3C2Tx grid collaborated with a self-designed leaf-like microfluidic. Ultimately, a wearable levodopa sensor composed of Au-Ti3C2Tx grid, microfluidic, flexible electronic system, and mobile phone client is established for detecting levodopa in human sweat, which is expected to help Parkinson's patients control the drug dosage. Our work proposes the vertically assembled Ti3C2Tx nanosheet loaded noble metal electrocatalysts to develop high-performance electrodes for electrochemical sensing.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 The cGAS-STING-Glymphatic-gut Axis in Parkinson's disease: A proposed self-amplifying triad of Neuroinflammation and therapeutic opportunity. International immunopharmacology 91.0 2 Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications. Cells 91.0 3 Flavonoids improve neurotransmitters for Parkinson's treatment: mechanism and therapeutic potential. Frontiers in pharmacology 88.0 4 Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives. Neurology international 78.0 5 The Gut Microbiota in Parkinson's Disease: Mechanistic Insights into Microbial-Host Interactions. Microorganisms 85.0 6 Linking inflammation, metabolic dysfunction, and neurodegeneration: a comprehensive review of TLR2 pathways in type 2 diabetes. Frontiers in clinical diabetes and healthcare 80.0 7 Neuroprotective effects of GLP-2 and a GLP-2/GIP dual receptor agonist in an MPTP-induced mouse model of Parkinson's disease. Peptides 86.0 8 TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation. Nature communications 91.5 9 Lipid Metabolism and Neurodegeneration: Mechanistic Insights and Therapeutic Targets. Ageing research reviews 82.0 10 Shared functional microbiome signatures in Parkinson's disease and constipation predominate irritable bowel syndrome despite taxonomic divergence. Brain, behavior, & immunity - health 80.0 11 Benzimidazole as a Versatile Scaffold for Developing Neurotherapeutics Against Neurodegenerative Diseases. ChemMedChem 74.0 12 Biomimicking neuromelanin reverses the gait deficits and dopaminergic neuronal loss in the Parkinson's disease. Colloids and surfaces. B, Biointerfaces 86.0 13 Neuroprotective roles of klotho: Molecular pathways and therapeutic implications for cognitive health in neurological and psychiatric diseases. Experimental physiology 84.0 14 Flavonoid Rutin Reduces Intestinal Inflammation in an Experimental Model of Parkinson's Disease. Neurotoxicity research 70.0 15 Nanostructured Lipid Carriers Enhance Brain Delivery and Antioxidant Efficacy of a Small-Molecule MAO B Inhibitor for Neurodegenerative Disease Therapy. Molecular pharmaceutics 78.0 16 Pathophysiological Role of the Gut Brain Axis in Parkinson's Disease: From Microbial Metabolites and Intestinal Permeability to Central Neuroinflammation. Current neurovascular research 86.0 17 Parkinson's Disease: From Metabolism to Genetics-A Comprehensive Review. Current issues in molecular biology 86.0 18 Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders. Neuroprotection (Chichester, England) 76.0 19 Integrative network pharmacology delineates dual GPCR and non-GPCR mechanisms of blended and individual Taikong Blue lavender and Pingyin rose essential oils in neurodegenerative and psychiatric disorders. Computers in biology and medicine 65.0 20 Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets. Experimental neurology 78.0 21 Hyaluronic acid: emerging roles and biomaterial innovations in Alzheimer's and Parkinson's disease therapy. Frontiers in pharmacology 75.2 22 Molecular mechanisms underlying Parkinson's disease and role of phytochemicals, α-synuclein, sirtuins, and incretin mimetics in potential therapy. Frontiers in pharmacology 75.0 23 Lipid droplets in neurodegenerative diseases: pathological drivers and therapeutic vulnerabilities. Cell death discovery 82.0 24 Brain-gut-microbiota axis: a review on the bidirectional regulatory mechanisms between gut microbiota and brain and their disease interactions. Frontiers in microbiology 74.0 25 Long non-coding RNAs in neurodegenerative diseases - Molecular mechanisms, liquid biopsy biomarkers, and therapeutic targets: A review. Biomolecules & biomedicine 84.0 26 Neurosyphilis and Parkinsonism: Overlapping Pathophysiology and Emerging Therapeutic Insights. Current neurovascular research 76.0 27 Molecular biochemistry of soluble epoxide hydrolase in lipid mediator pathways and neuroinflammatory responses. The Journal of steroid biochemistry and molecular biology 82.0 28 Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential. Cell stress 83.3 29 Neuroprotective Role of Exercise-based Physiotherapy Combined with Pharmacological Agents in Parkinson's Disease. Central nervous system agents in medicinal chemistry 64.0 30 Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder. Signal transduction and targeted therapy 84.0 31 HMGB1-mediated neuroinflammation: molecular mechanisms and emerging therapeutic approaches. Inflammopharmacology 78.0 32 Beyond acid-base dyshomeostasis: Dynamic instability of neuronal lysosomal pH as a pathogenic mechanism and therapeutic target in neurological diseases. Biochemical pharmacology 88.0
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic